As of November 2024, EyePoint Pharmaceuticals has a market cap of $428.80M. This makes EyePoint Pharmaceuticals the world's 12360th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.39B | 23.32% |
2023 | $1.13B | 560.29% |
2022 | $170.94M | -71.41% |
2021 | $597.79M | 86.02% |
2020 | $321.36M | -57.55% |
2019 | $757.00M | -17.99% |
2018 | $923.05M | 75.00% |
2017 | $527.46M | -36.84% |
2016 | $835.14M | -64.52% |
2015 | $2.35B | 17.27% |
2014 | $2.01B | 3.53% |
2013 | $1.94B | 228.10% |
2012 | $590.95M | 9.01% |
2011 | $542.11M | -78.28% |
2010 | $2.50B | 42.34% |
2009 | $1.75B | 281.91% |
2008 | $459.08M | -70.25% |
2007 | $1.54B | -59.49% |
2006 | $3.81B | -63.89% |
2005 | $10.55B | - |